Synergo® RITE
Recommended by the EAU and NICE guidelines, Synergo® delivers RITE (RF-Induced ThermoChemotherapeutic Effect) for Non-Muscle Invasive Bladder Cancer – simultaneous non-ionising radiation, cooled chemotherapy instillation, and tissue hyperthermia. Superior to chemotherapy and BCG, it provides durable, long RFS and low progression rates – also in BCG-failures and patients with carcinoma in situ (92% complete response at 8 weeks). It is a safe and easy procedure administered ambulatorially.
Medical Enterprises Europe B.V.
T: +31 (0)20 642 3719
